Biotech has reasserted itself over the past year as drug approvals, obesity and GLP-1 programs, oncology pipelines, and ...

Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

The longevity biotechnology industry is rapidly evolving with the amount of academic funding and venture investment increasing at the exponential pace. Over thirty longevity startups and approximately ...

The United States has led the world in biotechnology — an emerging field of science that connects molecular biology, engineering, medicine and plant science, and offers extraordinary potential for ...

China is pumping money into its biotech industry, helping launch a new wave of labs and incubators in the country. Experts say this could slow down American innovation in the biotech space. China's ...

Debut Biotech, a company innovating new molecules, is partnering with Image Skincare to launch a new beauty product, CNBC has learned. The San Diego-based company uses biotechnology and artificial ...

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...

Centuries before biotechnology had a name, humans were already practicing it – breeding animals for resilience, fermenting foods and treating pain with plants. Today, that same spirit of discovery ...

Investing in biotechnology stocks has always required a high risk tolerance and the patience to wait years, even decades, for results. These companies drive medical innovation, developing therapies ...

Sujal Patel, co-founder and CEO of Nautilus Biotechnology. (Nautilus Photo) Nautilus Biotechnology CEO Sujal Patel had to deliver tough news on a Thursday morning call with analysts. The company has ...

Unity Biotechnology and Mammoth Biosciences are both turning toward cost-saving measures, prompting layoffs at both companies. Unity’s restructuring comes along with 36-week results from its phase 2b ...